
Medpace Holdings (MEDP) P/E Ratio
P/E Ratio as of Nov 25, 2025: 42.79
Average41.50
Median41.41
Minimum40.59
Maximum43.26
42.79
0.46 (1.09%)past month
The P/E ratio for Medpace Holdings (MEDP) is 42.79 as of Nov 25, 2025. This represents a increase of 43.78% compared to its 12-month average P/E ratio of 29.76. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Medpace Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Medpace Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Medpace Holdings to industry peers.
Medpace Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Medpace Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Medpace Holdings to industry peers.
Medpace Holdings (MEDP) P/E Ratio Insights
See Medpace Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Medpace Holdings (MEDP)
Order type
Buy in
Order amount
Est. shares
0 shares
Medpace Holdings (MEDP) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Nov 3, 2025 | $594.02 | 41.54 |
| Oct 1, 2025 | $543.90 | 40.45 |
| Sep 2, 2025 | $473.34 | 35.20 |
| Aug 1, 2025 | $423.09 | 31.46 |
| Jul 1, 2025 | $321.065 | 24.50 |
| Jun 2, 2025 | $297.81 | 22.73 |
| May 1, 2025 | $302.25 | 23.07 |
| Apr 1, 2025 | $297.73 | 23.57 |
| Mar 3, 2025 | $319.17 | 25.26 |
| Feb 3, 2025 | $343.38 | 30.06 |
| Jan 2, 2025 | $334.75 | 29.31 |
Medpace Holdings (MEDP) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 42.79 | +47.10% |
| 2024 | 29.09 | -19.01% |
| 2023 | 35.92 | +10.25% |
| 2022 | 32.58 | -27.94% |
| 2021 | 45.21 | +24.82% |
| 2020 | 36.22 | — |
FAQs About Medpace Holdings (MEDP) P/E ratio
The latest P/E ratio of Medpace Holdings (MEDP) is 42.79, as of Nov 25, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Medpace Holdings’s last 12-month average P/E ratio is 29.76, compared to its current P/E ratio of 42.79. This reflects a increase of 43.78%.
Medpace Holdings’s current P/E ratio of 42.79 is higher than its last 12-month average P/E of 29.76. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Medpace Holdings’s average P/E ratio over the last 3 years is 31.55. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Medpace Holdings’s average P/E ratio over the last 5 years is 33.21. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.